9. January 2015

FDA Approves Roche's Blood Screening Assay for Simultaneous Detection and Identification of Three Major Viral Targets

Roche announced today that the FDA has approved the cobas® TaqScreen MPX Test, v2.0 for use in the detection and identification of HIV, HCV, and HBV in donations of human whole blood and blood components including source plasma.

>more

Learn about testing for Influenza
 
What's New

25. May 2016

Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients

New test standardizes CMV testing for both solid organ and hematopoietic stem cell transplant recipients.

>more

30. March 2016

Roche to initiate testing for Zika virus at U.S. Blood Centres under FDA Investigational New Drug Application protocol

New cobas® Zika test will screen blood samples on the cobas® 6800/8800 Systems.

>more

10. March 2016

Roche receives approval in Japan for the cobas® EGFR Mutation Test v2

New test includes expanded mutation coverage to detect EGFR mutations in non-small cell lung cancer patients.

>more

22. December 2015

New Roche HBV Test expands cobas® 4800 System menu

Complete virology portfolio strengthens high medical value capabilities.

>more

 Diagnostic and Blood Screening Tests

 

Roche Molecular Diagnostics (RMD) offers a uniquely broad range of diagnostic and blood screening assays based on the company's Nobel prize-winning PCR technologies.

 

RMD's tests and automated platforms are focused in the areas of virology, blood screening, HPV, genomics and oncology, microbiology and sexually transmitted infections. > more

 Contact

Contact your local sales representative for detailed information, questions and ordering.

 

 

 Browse Our Products

 Related Links